Irina Maric Selected Research

avelumab

1/2021

Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irina Maric Research Topics

Disease

13	Neoplasms (Cancer) 01/2020 - 01/2010
11	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2011
10	Multiple Myeloma 11/2021 - 01/2011
5	Smoldering Multiple Myeloma 11/2021 - 06/2014
5	Eosinophilia 01/2019 - 01/2008
5	Mastocytosis 12/2018 - 10/2009
4	Sickle Cell Anemia (Hemoglobin S Disease) 12/2015 - 08/2006
3	Systemic Mastocytosis 01/2022 - 01/2008
3	Residual Neoplasm 12/2021 - 01/2021
3	Disease Progression 01/2017 - 02/2015
3	Cytopenia 01/2016 - 06/2010
3	Leukemia 12/2013 - 02/2007
2	Hairy Cell Leukemia 12/2021 - 10/2020
2	Headache (Headaches) 01/2019 - 01/2016
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2019 - 01/2018
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2019 - 07/2018
2	Monoclonal Gammopathy of Undetermined Significance 01/2018 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 02/2016
2	Lymphoma (Lymphomas) 01/2017 - 06/2014
2	Lymphopenia (Lymphocytopenia) 02/2016 - 09/2011
2	Fibrosis (Cirrhosis) 01/2016 - 08/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016 - 08/2012
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2013 - 01/2011
2	Hyperplasia 04/2012 - 12/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2012 - 11/2010
2	Fever (Fevers) 08/2010 - 11/2004
1	Cutaneous Mastocytosis 01/2022
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Hemorrhage 10/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Infantile Epileptic-Dyskinetic Encephalopathy 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Immediate Hypersensitivity 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Autoimmune Lymphoproliferative Syndrome 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Circulating Neoplastic Cells 04/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2016
1	Hypersensitivity (Allergy) 02/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2016

Drug/Important Bio-Agent (IBA)

7	ibrutinibIBA 11/2020 - 02/2015
6	Chimeric Antigen ReceptorsIBA 01/2018 - 11/2010
4	Lenalidomide (CC 5013)FDA Link 11/2021 - 09/2015
4	carfilzomibIBA 11/2021 - 09/2015
3	Tryptases (Tryptase)IBA 01/2022 - 12/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 09/2015
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
3	B-Cell Maturation AntigenIBA 01/2018 - 01/2016
3	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2011 - 08/2006
2	Rituximab (Mabthera)FDA Link 12/2021 - 10/2020
2	Cladribine FDA LinkGeneric 12/2021 - 10/2020
2	purineIBA 12/2021 - 10/2020
2	Interleukin-5 (Interleukin 5)IBA 01/2019 - 11/2011
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2019 - 06/2015
2	AntibodiesIBA 07/2018 - 02/2016
2	Biomarkers (Surrogate Marker)IBA 03/2018 - 01/2017
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 09/2015
2	Proteasome InhibitorsIBA 01/2017 - 09/2015
2	Interleukin-7 (Interleukin 7)IBA 02/2016 - 01/2010
2	Fetal Hemoglobin (Hemoglobin F)IBA 01/2016 - 12/2015
2	Immunoglobulins (Immunoglobulin)IBA 11/2015 - 01/2011
2	Immunoglobulin M (IgM)IBA 06/2014 - 02/2006
2	Imatinib Mesylate (Gleevec)FDA Link 01/2008 - 11/2007
1	Omalizumab (Xolair)FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ofatumumab FDA Link 01/2021
1	serum P-component (CIt)IBA 01/2021
1	avelumabIBA 01/2021
1	fludarabineIBA 11/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2019
1	benralizumabIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Immunoglobulin E (IgE)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	aerolysinIBA 07/2018
1	Chromogranin AIBA 03/2018
1	DexpramipexoleIBA 01/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2018
1	SteroidsIBA 01/2018
1	Immunomodulating AgentsIBA 01/2017
1	CaspasesIBA 01/2017
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 01/2017
1	Chymotrypsin FDA Link 01/2017
1	TrypsinIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016

Therapy/Procedure

22	Therapeutics 01/2022 - 08/2006
3	Drug Therapy (Chemotherapy) 04/2012 - 11/2010
2	Hematopoietic Stem Cell Transplantation 04/2016 - 12/2013
1	Radiotherapy 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020
1	Cell Transplantation 01/2020
1	Subcutaneous Injections 01/2019